Selling screening
Health screening involves a fundamental change in the traditional relationship between patient and doctor. The offering of screening to apparently fit people reminds them that they may not be as well as they feel. They are told or led to assume that earlier diagnosis or the discovery of an abnormality is desirable. However, these are usually only desirable if effective intervention is available and if that intervention is more efficacious when given before the arrival of symptoms. Here I shall only consider screening procedures to have efficacy where these criteria apply.
In therapeutic medicine there is an increasing tendency to demand objective evidence of benefit before the adoption of new treatments as routine, and in particular evidence from randomized controlled trials. Mere assumption of benefit on theoretical grounds is often not considered adequate justification.
For a few screening procedures, e.g. for phenylketonuria in neonates, for visual impairment in pre-school children 1 and for breast carcinoma in those over the age of 50 years 2 , there is incontrovertible evidence of an overall chance of benefit for each participant. However, the chance is always low and frequently extremely low. Furthermore, even screening of proven efficacy will carry disadvantage for some participants.
No such proof of an overall chance of benefit is available for the majority of screening techniques. This is largely because randomized controlled trials have not been performed, because the results of such trials are not available or are inconclusive (e.g, screening for colorectal carcinomas), or because the results that are available show no benefit (e.g. screening for lung cancer'), No randomized trials of screening for cervical carcinoma have been performed but the evidence for efficacy, from a wealth of international experience showing that the intensity of screening is correlated with mortality reduction, is now almost universally considered indisputable.
There may be little or no evidence of benefit even for those who are discovered to have a treatable abnormality. In a controlled trial of treatment for hypertension detected at screening, it was shown that if 850 mildly hypertensive patients aged 35-64 are given antihypertensive drugs for one year, about one stroke will be prevented. A substantial percentage of patients will experience chronic side effects and treatment does not appear to reduce overall mortality", Where the chance of benefit is very low, it may be outweighed by the chance of disadvantage. Disadvantage may result from psychologicalmorbidity arising from the knowledge of the presence of disease or a risk factor, or from a false-positive result. 'Abnormalities' in laboratory tests are usually defined as values falling two standard deviations from the mean, and thus 5% of the population will show 'abnormal' results on any single test for statistical reasons alone", Disadvantage may result from a false sense of security leading to the ignoring of symptoms arising after a clear screen. It may result from physical morbidity and even mortality due to the investigation itself, or from further invasive investigations which a positive screening test result may set in train. It is not inconceivable that a young woman could die from a laparoscopy or laparotomy following a falsepositive result from an ultrasound ovarian scan.
Admittedly the chance of substantial disadvantage is usually low,but if participants are being encouraged to seek a low chance of benefit, should not the potential disadvantages be made equally clear? Professor Rose has said that 'health promotion efforts must be honest and direct and not borrow the manipulatory techniques of advertisers", Where those involved in the offering of screening stand to benefit financially, it is particularly important that objectivity is retained. Health screening is now widely available in private hospitals in the United Kingdom. This reflects an increasing demand and enthusiastic marketing, both of which are built on the obvious popularity of the message that prevention is better than cure. Undoubtedly lives have been saved and it seems highly probable that there has been overall benefit. However, such benefit may be largely due to the inclusion of the very few screening procedures which are of established efficacy.
Not only should the claims made for screening programmes be balanced and objective,but prospective participants should be given the opportunity to be informed of the evidence for advantage from the testis) being offered and the approximate magnitude of the chance of any benefit. Should they not also be told routinely of the possibility of disadvantage as a result of participation, and that a clear screen is no guarantee of freedom from disease?
Such information may deter some potential participants, but a more objective approach could carry its own particular appeal for others. They might be more easily recruited into randomized multi-centre studies of the efficacy of certain screening interventions. There is vast scope for evaluation.
There is also considerable scope for valuable prospective epidemiological research. Studies of participants in a screening programme at the British United Provident Association Medical Centre in London have demonstrated that low serum levels of vitamins A and E are a metabolic consequence rather than a precursor of cancer-", The opportunity should be taken to increase the amount of useful information that may be obtained from a medical activity which caters for a notably motivated sector ofthe population.
Is the sudden infant death syndrome preventable?
As deaths from asphyxia during labour, immaturity and infections have decreased rapidly over the past 50 years, the apparently irreducible causes of perinatal and infant death become more important in the minds of scientists and the population in general. The most striking example of this is the sudden infant death syndrome (SIDS). This is not strictly a syndrome at all, but rather a definition derived by elimination. The definition! applies to the death of any child 'which is unexpected by history and in whom a thorough necropsy examination fails to demonstrate an adequate cause of death'.
Typically such infants have been apparently well and given little cause for alarm, other than the common symptoms of early childhood. They are found dead in their cots, with no evidence to suggest a cause of death. Examination at postmortem tends to find minimal changes, although there are often signs of mild infection in the respiratory or gastrointestinal systems. By definition, the signs of the infection found at postmortem are not sufficient to explain the actual death.
Such deaths have probably occurred for centuries, but at a time when mothers kept the baby in their own bed, the cause was usually ascribed to overlaying'-", Only in the past 20 years has there been recognition of the existence of the problem, and even now many coroners and pathologists prefer to ascribe causes such as pneumonia, bronchiolitis or gastroenteritis rather than the more honest 'cause unknown' or SIDS4. Consequently, accurate estimates of the incidence of SIDS are impossible to obtain unless special population studies are mounted. In Britain, a number of studies where clinical history and necropsy findings of all deaths in a defined geographic population have been scrutinized have indicated an incidence ofat least 2.5 per 1000 Iivebirths". Studies in the United States have shown, in general, slightly lower incidences (between 2.0 and 2.5), but in New Zealand-the rate (4.9 per 1000) is much higher even than that found in the United Kingdom.
In the non-English speaking world, such data that exist indicate lower rates, especially in Scandinavia. Recent population studies from Sweden" and Finland? indicate incidences of around 0.5 per 1000 livebirths.
The majority of SIDS deaths occur between the second and fifth months of life, with a peak between 10 and 14 weeks of age. Very occasionally, cases occur in the first week of life", and they have been reported up to the fifth year of ages. Nevertheless, the major period of risk is within a very narrow period of the child's life. In both hemispheres, such deaths occur more frequently during the winter than during the summer. Nevertheless, attempts to link the death to the features of the weather pertaining at the time have generally failedt. As with most causes of morbidity and mortality, boys are more likely than girls to be affected.
The features of SIDS that strike the epidemiologists forcibly concern the maternal age (mothers of SIDS are consistently younger in all population studies than mothers of the population as a whole), birth order (the more children already in the family, the higher the risk of SIDS), social class (although there is little trend between social classes I, II and III, children of social classes IV and V do have an elevated risk), and marital status (children of unmarried mothers are at increased risk).
During pregnancy, the most replicable finding concerns the fact that mothers who smoked throughout pregnancy are much more likely to bear infants who later die of SIDS. There is also an independent association with maternal infections in pregnancy, whether these are of the respiratory or urinary tract. 0141·0768/88/ 020065·021$02.00/0 © 1988 The Royal Society of Medicine
